Atrial Fibrillation: Causes, Symptoms & Treatment – ScienceDaily
- Atrial fibrillation, or AFib, impacts a large number of individuals in the United States, with nearly one in three people facing this heart condition during their lives.
- A recent review in the Journal of the American Medical Association, conducted by researchers at Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, examined...
- Benjamin, conducted an extensive search of articles published between 1990 and 2024 to compile their findings.
Discover critical insights into atrial fibrillation (AFib), a prevalent heart condition impacting millions. This report breaks down the rising incidence of AFib, emphasizing the link between primary_keyword risk factors like hypertension and obesity and the advancement of an irregular heartbeat. Learn about advancements in diagnosis, including ECG monitoring and the role of implantable loop recorders. Explore effective management strategies, such as lifestyle adjustments and the potential of catheter ablation to improve outcomes for secondary_keyword patients. News Directory 3 provides expert analysis and the latest data. Understand the crucial steps toward early intervention and reducing the complications associated with AFib. Discover what’s next in research and treatment.
Understanding Atrial fibrillation: Prevalence, Risks, and Management
Updated June 25, 2025
Atrial fibrillation, or AFib, impacts a large number of individuals in the United States, with nearly one in three people facing this heart condition during their lives. AFib, characterized by an irregular heartbeat in the heart’s upper chambers, can lead to serious health issues, including stroke and heart failure.
A recent review in the Journal of the American Medical Association, conducted by researchers at Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, examined the latest data on AFib’s prevalence, how it develops, diagnosis methods, and treatment approaches. The study highlights the increasing need for effective strategies to reduce risk factors and prevent the onset and complications of atrial fibrillation.
The research team, led by Dr. Emelia J. Benjamin, conducted an extensive search of articles published between 1990 and 2024 to compile their findings. Their analysis revealed a significant increase in the incidence and prevalence of atrial fibrillation over the past three decades. The age-adjusted incidence rose from 3.7 to 13.4 per 1,000 person-years in men and from 2.5 to 8.6 in women. Similarly, prevalence increased from 20.4 to 96.2 in men and from 13.7 to 49.4 in women. The condition is more common in high-income countries and among men globally.
The study also identified key risk factors associated with atrial fibrillation, including hypertension, obesity, and valvular heart disease.These conditions contribute to changes in the atria, increasing the likelihood of developing AFib. The researchers emphasized the need for further investigation into health disparities in AFib outcomes among minority groups and those with lower socioeconomic status.
Regarding detection, the likelihood of diagnosing atrial fibrillation increases with longer electrocardiogram (ECG) monitoring. However,the value of widespread screening for asymptomatic AFib remains uncertain. implantable loop recorders can detect AFib in a significant portion of patients, while smartwatch notifications for irregular heart rhythms often require further confirmation through ECG patch monitoring.
Typical symptoms of atrial fibrillation include palpitations, shortness of breath, chest pain, fatigue, and feeling faint. Interestingly, asymptomatic AFib is more common in men and older adults, with diabetes being more prevalent in those without symptoms.
Initial management of atrial fibrillation involves lifestyle modifications such as weight loss,exercise,blood pressure control,smoking cessation,and limiting alcohol intake. According to Dr.Robert Helm, early intervention is gaining traction, and advances in catheter ablation make it an appealing option for many patients. Catheter ablation, an invasive procedure that destroys problematic heart muscle cells, has emerged as a first-line therapy for symptomatic paroxysmal AFib, improving symptoms and slowing progression.It is also recommended for AFib patients with heart failure to enhance quality of life and cardiovascular outcomes.
Benjamin said, “Given the increasing incidence, prevalence and lifetime risk of AF, it is imperative that we promote the most effective protocols to help reduce risk factors and prevent the onset, recurrence, and complications of AF in our patients.”
Helm added, “Consensus opinion is now moving in the direction of early intervention for AF to favorably influence outcomes.Technologic advances in catheter ablation have made this an attractive option for many patients.”
What’s next
Future research will likely focus on addressing health inequities in atrial fibrillation outcomes and refining screening and treatment strategies for diverse populations.